lupus New Phase 3 Study Shows that Gazyva® (obinutuzumab) Significantlyの詳細情報
New Phase 3 Study Shows that Gazyva® (obinutuzumab) Significantly。Treatment of severe lupus nephritis: the new horizon | Nature。Novel mitophagy inducer alleviates lupus nephritis by reducing。Cxcl9high macrophages recruit circulating Cxcr3+ plasmablasts into。種別...シングルカード 1枚